GLP-1 administration test for assessing the glucose metabolism and predictive efficacy of the incretin based treatment
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000010067
- Lead Sponsor
- Miyazaki university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with severe complication (proliferative retinopathy, serum cleatinine > 2.0 mg/dL, cerebrovascular disease, and/or ischemic heart diseases), severe liver dysfunction and/or dementia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Insulin secretion in GLP-1 administration compared to saline administration using meal tolerance test. 2. The relationship between the result of GLP-1 administration test and the changes of HbA1c after incretin based treatment.
- Secondary Outcome Measures
Name Time Method